Incidence of Extended Spectrum Beta-lactamase Producing Pseudomonas Aeruginosa and Frequency of OXA-2 and OXA-10 Genes
|
|
- Wilfrid Nichols
- 6 years ago
- Views:
Transcription
1 Australian Journal of Basic and Applied Sciences, 4(8): , 2010 ISSN Incidence of Extended Spectrum Beta-lactamase Producing Pseudomonas Aeruginosa and Frequency of OXA-2 and OXA-10 Genes 1 Tanaz, Alipour, 2 Nourkhoda, Sadeghifard, 3 Nour, amirmozafari, 2 Sobhan, Ghafurian, 4 Abdulamir, A.S., 2 Reza, Mohebi, 5 Fatimah, Abu Bakar, 5 Mohammad, Raftari 1 Dept of Microbiology,Azad University of Lahijan, Iran 2 Dept of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran 3 Dept of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran 4 Institute of Bioscience, Universiti Putra Malaysia, 43300, Serdang, Selangor 5 Faculty of Food Science and Technology, Universiti Putra Malaysia, 43300, Serdang, Selangor Abstract: Pseudomonas aeruginosa has emerged as a major cause of infection in the last few decades. The objective of this study was to determine the distribution of extended spectrum beta lactamaseproducing P. aeruginosa and the frequency of OXA-2 and OXA-10 genes. 350 and 120 P. aeruginosa samples were isolated from patients in two locations in Iran representing the region of the Middle East. Antibiotic pattern and OXA type ESBLs were detected by disk diffusion and PCR methods. Of 350 isolates of P. aeruginosa isolates in the first location, 105 (30%) isolates were positive for ESBLs from which 92 (87.61%) isolates were positive for OXA-10 Type ESBLs while only 5 (4.76%) isolates were positive for OXA-2 ESBLs by using PCR methods in Ilam hospitals. In the second location, 46 (38.33%) of P. aeruginosa isolates were positive for ESBLs of which 29 (63%) were positive for OXA-10 Type ESBLs and only 1 (2.1%) isolates were positive for OXA-2 ESBLs by PCR methods in Kerman hospitals. Results of the current study showed the presence of high percentage of OXA genes, 2 and 10, ESBLs in the region of the Middle East associated with extended resistance profile against almost all cephalosporins. Moreover, comparing the results of the studied two cities indicated that distribution of OXA type ESBLs is locally diverse even in the same geographical region. Key words: Pseudomonas aeruginosa, OXA-2, OXA-10, Gene, ESBLs INTRODUCTION The accelerated emergence of antibiotic resistance among the prevalent pathogens is the most serious threat to the management of infectious diseases. -lactamases antibiotics are the most common treatment for bacterial infections (Blanc,et al1998). Pseudomonas aeruginosa (P. aeruginosa) is responsible for 10 15% of nosocomial infections worldwide (Blanc,et al1998). The infections are frequently difficult to treat because of both the natural resistance of the species and its remarkable ability to acquire resistance to multiple groups of antimicrobial agents. P. aeruginosa represents a phenomenon of antibiotic resistance, demonstrating practically all known enzymic and mutational mechanisms of bacterial resistance. These mechanisms are often present simultaneously, conferring combined resistance to many strains (McGowan, 2006). Unfortunately, extended-spectrum -lactamases (ESBLs) have been widely spread throughout serious infections of Gram-negative bacteria in the 1980 s (Bradford, 2001). The first report of plasmid-encoded lactamases capable of hydrolyzing the extended spectrum cephalosporins was published in 1983 (Khan,et al1998). Hence, ESBLs are able to hydrolyze a broader spectrum of -lactamases antibiotics than the simple parent -lactamases from which they are derived. ESBLs have an ability to inactivate antibiotics containing an oxyimino-group such as oxyimino-cephalosporins (e.g., ceftazidime, ceftriaxone, cefotaxime) as well as oxyimino-monobactam (aztreonam) (Bradford, 2001); however, they are not active against cephamycins and carbapenems. Generally, they are inhibited by -lactamase-inhibitors such as clavulanate and tazobactam (Yan,et al, 2006). Corresponding Author: Faculty of Food Science and Technology, Universiti Putra Malaysia, 43300, Serdang, Selangor Mohammad_Raftari@yahoo.com 3202
2 P. aeruginosa has emerged as a major cause of infection in the last few decades. It is an increasingly prevalent opportunistic pathogen and is the fourth most frequently isolated nosocomial pathogen accounting for 9.9% of all hospitals acquired infections (Khan at al, 1998; Gordon et al, 998). In burn units, P. aeruginosa outbreak leads to high mortality of up to 60 % (Richard et al, 1994 ). Various types of ESBLs have been identified in P. aeruginosa including class A ESBLs, such as TEM, SHV, PER and VEB ESBLs, and class D, such as OXA-type ESBLs.. Among them, OXA type ESBLs have been encountered most commonly in P. aeruginosa while class A ESBLs were found uncommon (Livermore, 2002,De Champs,2002). Furthermore, most OXA-type ESBLs are OXA-2 and OXA-10 derivatives (Livermore, 2002). The OXA-type ESBLs were originally discovered in P. aeruginosa isolates from a single hospital in Ankara, Turkey (Hall et al., 1993). Several OXA-type ESBLs have been derived from the original OXA-10 -lactamase (e.g., OXA -11, 14, 6 and 17) (10-12). OXA-type -lactamases are characterized by their high hydrolytic activity against oxacillin and cloxacillin and are poorly inhibited by clavulanic acid. Extension of the hydrolytic spectrum of oxacillinase to oxyimino cephalosporins has been reported in OXA-2 and OXA-10 extended-spectrum derivatives (13). In contrast to the majority of OXA-type ESBLs, which confer resistance to ceftazidime, the OXA-17 -lactamase confers resistance against cefotaxime and ceftriaxone but provides only marginal protection against ceftazidime (Danel, et al, 1999). Many of the newer members of OXA-type ESBLs have been found mainly in P. aeruginosa isolates originating from Turkey and France (Hall, 1993; Philippon 1997). Despite the growing awareness of the impact of OXA-type ESBLS in the combat against bacterial infections, there have been few studies in different parts of the world conducted on the epidemiology and geographical spread of OXA-type ESBLs. This study was conducted to determine the distribution of extended spectrum -lactamase producing P. aeruginosa and frequency of OXA-2 and OXA-10 genes in Kerman & Ilam hospitals. MATERIALS AND METHODS Bacterial Isolates: A total of 350 and 120 P. aeruginosa samples were collected from Ilam and Kerman hospitals respectively between April 2007 to March Pseudomonas aeruginosa isolates were identified by using standard chemical methods (Pollack, 2000). Detection of ESBLs in Pseudomonas aeruginosa: Standard disk diffusion method in vitro sensitivity testing- using established NCCLS procedure was carried out with cefpodoxime (30 μg), cefotaxime(30 μg), ceftazidime (30 μg), aztreonam (30 μg), ceftriaxon (30 μg), amikacin (30 μg), cotrimoxazol (30 μg), imipenem (30 μg), and oxaciline (30 μg) (Hi Media, India). PCR-based detection of ESBLs Genes Isolates were cultured in LB broth for 24 hours at 37 C and DNA was extracted by DNA extraction Kit (Fermentas, UE). The used primers for OXA-2 gene were: Forward 5-GCC AAA GGC ACG ATA GTT GT-3 and reverse 5-GCG TCC GAG TTG ACT GCC GG-3. This set of primers was used to amplify 700bp fragment of OXA-2 gene. On the other hand, the primers for OXA-10 were forward: 5-GT CTT TCG AGT ACG GCA TTA -3 and reverse 5-ATT TTC TTA GCG GCA ACT TAC-3. This set of primers was used to amplify a 720bp fragment of OXA-10 gene. All used PCR reagents were from (Promega Corporation, Madison, USA). OXA-2 gene was amplified under the following condition: the initial denaturation was for 5 minutes at 94 C, followed by 35 cycles of denaturation for 30 seconds at 95 C, annealing for 1 minute at 50 C, and extension for 1 minute at 72 C, and a final extension step for 10 minutes at 72 C. On the other hand, OXA-10 gene was amplified under the following condition: the initial denaturation was for 5 minutes at 94 C, followed by 35 cycles of denaturation for 30 seconds at 95 C, annealing for 1 minute at 54 C, and extension for 1 minute 72 C, and a final extension step for 10 minutes at72 C (De Champs,2000,Vahaboglu, 1998). It is noteworthy to mention that negative control, master mix devoid of genomic DNA, and positive control, a strongly consistent positive sample, were used simultaneously in duplicates. PCR products, amplicons, were run in 1% agarose gel. The gels were stained with ethidium bromide (Sigma, USA) and a single band was observed at the desired position on ultraviolet light transilluminator (Vilber Lourmat, Cedex, France); bands were photographed using gel documentation system (Bio Rad Gel Doc 2000 Model Imaging System). 3203
3 RESULTS AND DISCUSSION Many studies have investigated the prevalence of ESBLs in P. aeruginosa; according to these studies, a diverse range of ESBLs is currently emerging inhospitals (Weldhagen, 2003; Chanawong, 2001; Ben-Hamouda, 2004). Because of the large number of new -lactamases, some with identical or very similar isoelectric points, described in P. aeruginosa in the past few years, isoelectric focusing can no longer be considered an effective method of identifying -lactamases in this species. Therefore, epidemiological studies might better use PCRbased detection tests followed by analysis of PCR products by sequencing or restriction with endonucleases for detecting changes generated by point mutations. PCR restriction fragment length polymorphism (RFLP) analysis has been successfully applied to the identification of TEM -lactamases in Enterobacteriaceae (Arlet,1995). In P. aeruginosa, PCR use has been limited to the detection of OXA-10-derived ESBLs without fully differentiating variants within this group (Vahaboglu,1998). The main difficulty in applying PCR RFLP to the characterization of oxacillinases is that they constitute a heterogeneous group of enzymes, including subgroups with large evolutionary distances between them (Sanschagrin, et al, 1995). The results of the current study showed that 105 (30%) of 350 isolates of P. aeruginosa isolates were positive for OXA gene by screening disk diffusion methods (Table 1); Interestingly, by PCR methods, 92 (87.61%) isolates were positive for OXA-10 Type ESBLs while only 5 (4.76%) isolates were positive for OXA-2 ESBLs where two of them were positive for OXA-10 and OXA-2 at the same time. Ten (9.52%) isolates were negative for OXA genes by PCR (Figure 1). Table 1: Antimicrobial resistance pattern for Pseudomonas aeruginosa in Ilam hospitals patients P.aeroginosa Ceftazidim Cefteriaxon Oxacilin Amikacin Imipenem Tikaricilin Azteronam N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) Urine (60) (76.19) (60) (32.38) (71.42) (5.71) (39.04) (40.95) septum (24.86) (62.06) (43.67) (29.88) (55.17) (5.74) (49.42) (37.93) Burn (15.14) (39.62) (33.96) (20.75) (66.03) (3.77) (54.71) (26.41) Total 350 (100) 235 (67.14) 182 (52) 105 (30) 233 (66.5) 19 (5.4) 154 (44) 133 (38) As far as our knowledge, this study presents the first report of isolation of P. aeruginosa isolates harbouring OXA-2 and 10 groups of ESBLs in the region of the Middle East. In this study, of 350 P. aeruginosa samples in Ilam Hospitals, 133 isolates were resistant to azteronam and 3 rd generation of cephalosporin and suspect to Amblers class A ESBLS and 105 isolates were resistant to oxacilin and suspect to OXA type of ESBLs. Distribution of P. aeruginosa with OXA type gene from highest to lowest was in urine, sputum, and burn patients. There is no phenotypic confirmatory method for the presence of OXA gene in P. aeruginosa (Kernodle, and Kaiser, 2000). Hence, the current study provides precise and the only reliable genotypic method for detecting OXA resistance genes in P. aeruginosa. In a similar study conducted by Bert et al. (Bert, et al, 2002), they reported that PCR detecting OXA-10 gene in P. aeruginosa isolates was positive in 68 (26.3%) isolates; 31 carried blaoxa-10, one carried blaoxa-14 and 36 carried a new variant intermediate between blaoxa-13 and blaoxa-19. Two other isolates carried blaoxa-2 variants encoding ESBLs differing from OXA-2 by a single amino acid substitution (Asp150 to Tyr and Trp159 to Cys, respectively). In the current study, resistance P. aeruginosa isolates against ceftazidim, cefteryaxon, tikaricilin, amikacin, and azteronam were seen along with oxacilin but, the distribution of resistant P. aeruginosa against imipenem was minimal. The results of the current study were found to be congruous with that of previous studies. The resistance pattern observed in other studies for P. aeruginosa ED-1 resembled that of OXA-15, an extendedspectrum derivative of OXA-2 (Danel et al, 1997). And it was stated that most of the extended-spectrum oxacillinases confer resistance to ceftazidime and cefotaxime which are not inhibited significantly by clavulanic acid (Danel, et al, 1998; Danel, 1995; Mugnier, 1998). Ceftazidime resistance in P. aeruginosa is most often caused by hyperproduction of the chromosomal class C cephalosporinase or by efflux or impermeability; these mechanisms raise the MICs of ureidopenicillins and cefotaxime above that of ceftazidime (Chen, et al, 1995). Levels of antimicrobial susceptibility and mechanisms of resistance to antipseudomonal agents of P. aeruginosa were evaluated by a European team, Strateva et al., (2007) who showed close results to our study except for Impinem. They surveyed 203 clinical isolates and reported that the antibiotic resistance rates against the following antimicrobials were: carbenicillin 93.1%, azlocillin 91.6%, piperacillin 86.2%, piperacillin/tazobactam 56.8%, ceftazidime 45.8%, cefepime 48.9%, cefpirome 58.2%, aztreonam 49.8%, 3204
4 imipenem 42.3%, meropenem 45.5%, amikacin 59.1%, gentamicin 79.7%, tobramycin 89.6%, netilmicin 69.6% and ciprofloxacin 80.3%. They reported that structural genes encoding class A and class D -lactamases were as follows: blaveb %, blapse %, blaper-1 0%, blaoxa-groupi 41.3% and blaoxa-groupii 8.8%. This indicates that the genetic pool of P. aeruginosa in Europe and in the Middle East are highly alike. Therefore, the pattern of antimicrobial resistance in either region can be of high predictability for the other region. Nevertheless, resistance against imipenem was found minimal in the region of the Middle East when compared to that observed in Europe. Taken that resistance against imipenem is a serious problem for treating patients with P. aeruginosa infection, the overall effectiveness of antipseudomonal agents in the Middle East might be better than that in Europe. In Kerman hospitals, of 120 P. aeruginosa isolates 46 (38.33%) isolates were positive for OXA gene by disk diffusion method (Table 2). Of 46 OXA-positive P. aeruginosa isolates, by PCR methods, 29 (63%) were positive for OXA-10 Type ESBLs and 1 (2.1%) isolate was positive for OXA-2 ESBLs which was positive to both OXA-2 and OXA-10 (Figure 1). Table 2: Antimicrobial resistance pattern for Pseudomonas aeruginosa in Kerman hospitals patients ceftazidim cefteriaxon oxacilin amikacin imipenem Tikaricilin azteronam Burn 78(65%) 54(45%) 46(38.33) 69(57.5%) - 65(54.1%) 72(60%) Fig. 1: Gel electrogram of PCR products of isolated P. aeruginosa with positive OXA-10 gene, 720 bp, (lanes 1-5) and OXA-2 gene, 700 bp, (lanes 7-9). (Lane 6) is the negative control and (M) is the molecular weight ladder (scale 50bp). Interestingly, in Kerman hospitals, it was found that there was no resistance of P. aeruginosa isolates against imipenem. The results also showed a remarkable high resistance to azteronam, 60%, which determines an ESBL type of P. aeruginosa in Kerman different from that in Ilam using the disk diffusion method. This provided evidence that the antimicrobial resistance of P. aeruginosa can be finely diverse even in the closely related geographical regions. However, in both Kerman and Ilam, the rate of P. aeruginosa isolates with OXA- 10 was high and close to each other. This indicates that Oxacillin resistance of P. aeruginosa in the Middle East region seems to be essential. Nevertheless, in a previous survey on burn patients in Tehran hospitals in (Mirsalehian, et al 2008), only 29% of isolates were OXA-10 positive which is far lower than that found in the current study. This can be explained that OXA genes are acquired more quickly than other genes and spread progressively in the population of P. aeruginosa bacteria. Therefore, this pinpoints to the importance of conducting frequent screenings of antimicrobial resistance of P. aeruginosa and conducting particularly frequent genotypic screenings on OXA genes in P. aeruginosa. Similar to Ilam hospitals, P. aeruginosa isolates in Kerman showed very clear extended spectrum of cephalosporins resistance which strengthening the proposed correlation between OXA genes infiltration in P. aeruginosa population and the extended-spectrum cephalosporins resistance. Conclusions: In conclusion, this study highlighted the contribution of the OXA-2 and 10 ESBLs to the extendedspectrum cephalosporins resistance in P. aeruginosa of the Middle East region. Moreover, this study identified an OXA-2 and 10 producing strain of P. aeruginosa for the first time in the Middle East region. Early detection of these isolates and conducting frequent screenings could acquire good information concerning their 3205
5 dissemination as outbreaks caused by P. aeruginosa are usually difficult to control. Finally, P. aeruginosa may, like the Enterobacteriaceae, constitute a reservoir of ESBL genes. The spread of P. aeruginosa strains producing OXA-2 and 10 may be enhanced by under detection. ACKNOWLEDGMENT This research would not have been possible without the help of the physicians and specialists who participated in collecting bacterial samples. REFERENCES Arlet, G., G. Brami, D. Decre, A. Flippo, O. Gaillot, P.H. Lagrange and A. Philippon, Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiology letters, 134(2): Ben-Hamouda, T., T. Foulon and K. Ben Mehrez, Involvement of SHV-12 and SHV-2a encoding plasmids in outbreak of extended-spectum b-lactamase-producing Klebsiella pneumonia in Tunisia neonatal ward. Microbial Drug Resistance, 10(2): Bert, F., C. Branger and N.L. Zechovsky, Identification of PSE and OXA b-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. Journal of Antimicrobial Chemotherapy, 50(3) :11 8. Blanc, D.S., C. Petignat, B. Janin, J. Bille and P. Francioli, Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clinical Microbiology and Infection., 4(5): Bradford, P.A., Extended spectrum beta-lactamases in the 21 st century: characterization, epidemiology and the detection of this important resistance threat. Clinical Microbiological Reviews, 14(4): Chen, H.Y., Yuan, M. and Livermore, D.M. (1995). Mechanisms of resistance to b-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in Journal of Medical Microbiology, 43(5): Chanawong, A., F.H. M'Zali, J. Heritage, A. Lulitanond and P. M. Hawkey, SHV-12, SHV-5, SHV- 2a and VEB-1 extended spectrum b-lactamase in gram negative bacteria isolated in a university hospital in Thailand. J Antimicrob Chemother, 48(6): Danel, F., L.M.C. Hall, D. Gur and D.M. Livermore, OXA-16, a further extended-spectrum variant of OXA-10 B-lactamase, from two Psuedomonas aerurginosa isolates. Antimicrobial Agents and Chemotherapy, 42(3): Danel, F., L.M.C. Hall, D. Gur and D.M. Livermore, OXA-14, another extended - spectrum variant of OXA-10(PSE-2) B-lactamase from Psuedomonas aerurginosa. Antimicrobial Agents and Chemotherpy, 39(4): Danel, F., L.M.C. Hall, B. Duke, D. Gur and D.M. Livermore, OXA- 17, a further extendedspectrum variant of OXA-10 ßlactamase, isolated from Psuedomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 43(1): Danel, F., L.M.C. Hall, D. Gur and D.M. Livermore, OXA-15, an extended-spectrum variant of OXA-2 b-lactamase isolated from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherpy, 41(2): De Champs, C., L. Poirel, R. Bonnet, D. Sirot, C. Chanal and J. Sirot, Prospective survey of B- lactamases produced by ceftazidim resistance pseudomonas aeruginosa isolated in a French hospital in Antimicrobial Agents and Chemotherapy, 46(2): Gordon, S.M., J.M. Serkey, T.F. Keys, T. Rayan, C.A. Fatica and S.K. Schmitt, Secular trends in nosocomial blood stream infections in a 55 bed cardiothoracic intensive care unit. The Annals of Thoracic Surgery, 65(2): Hall, L.M., D.M. Livermore, D. Gur, M. Akova and H.E. Akalin, OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Psuedomonas aerurginosa. Antimicrobial Agents and Chemotherapy, 37(6): Kernodle, D.S., A.B. Kaiser, Post operative infections and antimicrobial prophylaxis, In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, Eds., Mandell, Gerald L., R. Gordon Douglas and John E. Bennett. New York, Churchill Livingstone, A Harcourt Health Sciences Company, pp:
6 Khan, F.G., A. Rattan, I.A. Khan and A. Kalia, Study of Pseudomonas aeruginosa causing ventrilatory associated pneumonia. Indian Journal of Medical Research, 107(3): Livermore, D.M., Multiple mechanisms of antimicrobial resistance in pseudomonas aeruginosa. Clinical Infectious Diseases., 34(8): McGowan, J.E., Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. American journal of Medicine, 119(10):29 S36. Mirsalehian, A., M. Feizabadi, F. Akbari Nakhjavani, F. Jabal ameli and H. Goli, Prevalence of extended spectrum beta lactamases among strains of Pseudomonas aeruginosa isolated from burn patients. Tehran University Medical Journal, 66(5): Mugnier, P., I. Casin, I., A.T. Bouthors and E. Collatz, Novel OXA-10- derived extended-spectrum b-lactamases selected in vivo or in vitro. Antimicrobial Agents and Chemotherapy, 42(7): Philippon, L.N., T. Nass, A.T. Bouthor, V. Barakett, P. Nordmann, OXA-18, a class D clavulanic acid-inhibited extended spectrum ß-lactamase from Psuedomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 41(5): Pollack, M., Pseudomonas Aeruginosa. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, Eds., Mandell, Gerald L., R. Gordon Douglas and John E. Bennett. New York, Churchill Livingstone, A Harcourt Health Sciences Company, pp: Richard, P., R. Le Floch, C. Camoux, M. Pannier, E. Espaze, and H. Ricket, Pseudomonas Aeruginosa outbreak in a burn unit: Role of antimicrobials in the emergence of multiply resistant strains. Journal of Infectious Diseases, 170(11): Sanschagrin, F., F. Couture, and R.C. Levesque, Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D -lactamases. Antimicrobial Agents and Chemotherapy, 39(2): Strateva, T., V. Ouzounova-Raykova, B. Markova, A. Todorova, Y. Marteva-Proevska and I. Mitov, Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. Journal of Medical Microbiology, 56(7): Vahaboglu, H., R. Ozturk, H. Akbar, S. Saribas, O. Tansel and F. Coskunkan, Practical approach for detection and identification of OXA-10-derivative ceftazidim-hydrolysing extended spectrum B-lactamases. Journal of Clinical Microbiology, 36(8): Weldhagen, G.F., L. Poirel and P. Nordmann, Ambler Class A extended-spectrum b-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrobial Agents and Chemotherapy, 47(4): Yan, J.J., S.H. Tsai, C.L. Chung and J.J. Wu, OXA-type beta-lactamases among extended spectrum cephalosporin-resistance pseudomonas aeroginosa isolates in a university hospital in southern Taiwan. Journal of Microbiology, Immunology and Infection, 39(1):
The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics in Klebsiella pneumoniae isolates from clinical samples and plasmid curing
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 11:557-561 The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics
More informationOXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan
OXA-type J Microbiol ESBLs Immunol in P. Infect aeruginosa 2006;39:130-134 OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital
More informationEvaluation of the Osiris Expert System for Identification of -Lactam Phenotypes in Isolates of Pseudomonas aeruginosa
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2003, p. 3712 3718 Vol. 41, No. 8 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.8.3712 3718.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationThe biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush
International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.
More informationDetection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia coli
ISSN: 2319-7706 Volume 2 Number 8 (2013) pp. 196-205 http://www.ijcmas.com Original Research Article Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia
More informationDepartment of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & *
Indian J Med Res 122, October 2005, pp 330-337 Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum
More informationH. Wu, B.-G. Liu, J.-H. Liu, Y.-S. Pan, L. Yuan and G.-Z. Hu
Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province,
More informationIOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. VII (Oct. 2017), PP 76-81 www.iosrjournals.org Molecular Characterization of TEM, SHV
More informationPrevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype
J Antimicrob Chemother 2010; 65: 460 464 doi:10.1093/jac/dkp484 Advance publication 22 January 2010 Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 8, September 2014
EVALUATION OF CHROMAGAR-CTX FOR THE DETECTION OF CTX-M-ESBL- PRODUCING GRAM NEGATIVE BACTERIAL ISOLATES RASHA H. ELSHERIF* LAMIAA A. MADKOUR** REHAM A. DWEDAR*** *Clinical Pathology Department, Faculty
More informationOngoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
Journal of Antimicrobial Chemotherapy (2008) 61, 59 63 doi:10.1093/jac/dkm443 Advance Access publication 13 November 2007 Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece:
More informationReceived 6 July 2004; returned 14 August 2004; revised 6 September 2004; accepted 8 September 2004
Journal of Antimicrobial Chemotherapy (2004) 54, 870 875 DOI: 10.1093/jac/dkh449 Advance Access publication 7 October 2004 Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum
More informationNosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit
Available online at www.annclinlabsci.org 297 NosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit Yang-Ree Kim, 1 Sang-Il Kim, 1
More informationCloning and Characterization of E. meningoseptica Beta Lactamase
Cloning and Characterization of E. meningoseptica Beta Lactamase Authors: Lindsey Purcell, Jessica Matts, Patricia Canaan* Department of Biochemistry and Molecular Biology Abstract Elizabethkingia meningoseptica
More informationReceived 30 October 2003/Returned for modification 28 January 2004/Accepted 14 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3086 3092 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3086 3092.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationExtended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia
Current Research in Microbiology Original Research Paper Extended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia 1 Viera
More informationAdd 5µl of 3N NaOH to DNA sample (final concentration 0.3N NaOH).
Bisulfite Treatment of DNA Dilute DNA sample to 2µg DNA in 50µl ddh 2 O. Add 5µl of 3N NaOH to DNA sample (final concentration 0.3N NaOH). Incubate in a 37ºC water bath for 30 minutes. To 55µl samples
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02030.x Metallo-b-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya J. D. D. Pitout 1,2,3, G. Revathi 4, B. L Chow 1, B.
More informationTitle: Description of the First Escherichia coli Clinical Isolate Harboring Colistin-
AAC Accepted Manuscript Posted Online 24 October 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01945-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 Title: Description
More informationOXA-18, a Class D Clavulanic Acid-Inhibited Extended-Spectrum -Lactamase from Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1997, p. 2188 2195 Vol. 41, No. 10 0066-4804/97/$04.00 0 Copyright 1997, American Society for Microbiology OXA-18, a Class D Clavulanic Acid-Inhibited Extended-Spectrum
More informationEzy MIC Strip FEATURES AND ADVANTAGES
Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal
More informationVariable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum β-lactamases
Journal of Antimicrobial Chemotherapy (2003) 51, 605 612 DOI: 10.1093/jac/dkg114 Advance Access publication 28 January 2003 Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with
More informationExtended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system
Journal of Medical Microbiology (2011), 60, 756 760 DOI 10.1099/jmm.0.024075-0 Extended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system Maria José Espinar,
More informationJAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases
Journal of Antimicrobial Chemotherapy (1999) 43, 23 29 JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases
More informationstrain devoid of the aox1 gene [1]. Thus, the identification of AOX1 in the intracellular
Additional file 2 Identification of AOX1 in P. pastoris GS115 with a Mut s phenotype Results and Discussion The HBsAg producing strain was originally identified as a Mut s (methanol utilization slow) strain
More informationMolecular investigation of extendedspectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii
Molecular investigation of extendedspectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii Abbas S. Al-Muhanna, a Sddiq Al-Muhanna, a Maytham A. Alzuhairi
More informationRaymond G. Batchoun, Samer F. Swedan, and Abdullah M. Shurman. 1. Introduction
Hindawi Publishing Corporation International Journal of Microbiology Volume 2009, Article ID 513874, 8 pages doi:10.1155/2009/513874 Research Article ExtendedSpectrumβ-Lactamases among Gram-Negative Bacterial
More informationOriginal article DOI: Journal of International Medicine and Dentistry 2016; 3(1): 34-41
Original article DOI: http://dx.doi.org/10.18320/jimd/201603.0134 JOURNAL OF INTERNATIONAL MEDICINE AND DENTISTRY To search..to know...to share p-issn: 2454-8847 e-issn: 2350-045X Comparative analysis
More informationInvestigation of Klebsiella pneumoniae Isolates Producing SHV-12 and SHV-11 β-lactamases in Korean Hospitals
J. Microbiol. Biotechnol. (2009), 19(2), 000 000 doi: 10.4014/jmb.0808.472 First published online 3 June 2009 Investigation of Klebsiella pneumoniae Isolates Producing SHV-12 and SHV-11 β-lactamases in
More informationThe occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria by a simple..
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 12 Ver. I (Dec. 2015), PP 19-24 www.iosrjournals.org The occurrence of AmpC β-lactamase and
More informationCRE is not the first organism we ve had that has become resistant to antibiotics, so why is it so important? CRE resistance is complex because it can
1 Enterobacteriaceae are a large family of bacteria that are a normal part of a person's digestive system (2). Examples include Escherichia coli and species of the genera Klebsiella, Enterobacter, Serratia,
More informationCombatting AMR: diagnostics
Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Quan J, Li X, Chen Y, et al. Prevalence of
More informationA Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae
A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease
More informationA Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1
A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease
More informationBecause of increasing rates of antimicrobial resistance in
Emergence of Ceftriaxone-Resistant Salmonella Isolates and Rapid Spread of Plasmid-Encoded CMY-2 Like Cephalosporinase, Taiwan Jing-Jou Yan,* Wen-Chien Ko,* Cheng-Hsun Chiu, Shu-Huei Tsai,* Hsiu-Mei Wu,*
More informationReceived 24 June 2008/Returned for modification 12 August 2008/Accepted 14 September 2008
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2008, p. 4268 4273 Vol. 52, No. 12 0066-4804/08/$08.00 0 doi:10.1128/aac.00830-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. High
More informationDisease and selection in the human genome 3
Disease and selection in the human genome 3 Ka/Ks revisited Please sit in row K or forward RBFD: human populations, adaptation and immunity Neandertal Museum, Mettman Germany Sequence genome Measure expression
More informationElectronic Supplementary Information
Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2017 Electronic Supplementary Information Dissecting binding of a β-barrel outer membrane
More informationInternational Journal of Pharma and Bio Sciences PHENOTYPIC DETECTION OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN WOUNDS ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 PHENOTYPIC DETECTION OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN WOUNDS SANDHYA RANI T* 1
More informationMetallo-β-lactamase (MBL) project: From molecular biology to the development of an MBL-inhibitor
Metallo-β-lactamase (MBL) project: From molecular biology to the development of an MBL-inhibitor Indo-Norwegian Workshop on Antimicrobial Resistance Tromsø, Norway 26-27 th of September 2013 Ørjan Samuelsen
More informationEvaluation of a 12 Disc Test for Phenotypic Detection of β- lactamases Resistance in Gram Negative Bacilli
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 6 (2016) pp. 105-114 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.506.013
More informationThe GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity
Promega Notes Magazine Number 62, 1997, p. 02 The GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity By Christine Andrews and Scott Lesley Promega
More informationAmpicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different -Lactam Resistance Phenotypes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1999, p. 862 867 Vol. 43, No. 4 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Ampicillin-Sulbactam and Amoxicillin-Clavulanate
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationPrevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy
Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Sponsored by: Presentation by: Lawrence F. Muscarella, Ph.D. President LFM Healthcare
More informationFrequency and diversity of Class A extended-spectrum b-lactamases in hospitals of the Auvergne, France: a 2 year prospective study
Journal of Antimicrobial Chemotherapy (2004) 54, 634 639 DOI: 10.1093/jac/dkh395 Advance Access publication 28 July 2004 JAC Frequency and diversity of Class A extended-spectrum b-lactamases in hospitals
More information3-Lactamase in Enterobacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1984, p. 268-272 0066-4804/84/020268-05$02.00/0 Copyright 1984, American Society for Microbiology Vol. 25, No. 2 Detection of PSE-2 3-Lactamase in Enterobacteria
More informationPrevalence of Metallo- -Lactamases Producing Pseudomonas aeruginosa among the Clinical isolates: A study from tertiary care hospital
ISSN: 2319-7706 Volume 4 Number 4 (2015) pp. 955-961 http://www.ijcmas.com Original Research Article Prevalence of Metallo- -Lactamases Producing Pseudomonas aeruginosa among the Clinical isolates: A study
More informationDETECTION OF AMBLER CLASS A, B AND D ß-LACTAMASES AMONG PSEUDOMONAS AERUGINOSA AND ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM BURN PATIENTS
DETECTION OF AMBLER CLASS A, B AND D ß-LACTAMASES AMONG PSEUDOMONAS AERUGINOSA AND ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM BURN PATIENTS Hakemi Vala M., 1 Hallajzadeh M., 1 Hashemi A., 1 * Goudarzi
More informationAn extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection
FEMS Microbiology Letters 165 (1998) 85^90 An extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection Mar èa-isabel Morosini a, Mar èa-cristina Negri a, Brian Shoichet b, Mar
More informationPrevalence of CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of
Arch Clin Infect Dis. 2015 April; 10(2): e22540. Published online 2015 April 22. DOI: 10.5812/archcid.22540 Research Article Prevalence of CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Escherichia
More informationKey words: Extended spectrum β-lactamase (ESBL), Double Disk Synergy Test (DDST), Antibiogram, Plasmid, PCR
DOI: 10.7860/JCDR/2013/6460.3462 Microbiology Section Original Article Prevalence and antibiogram of Extended Spectrum β-lactamase (ESBL) producing Gram negative bacilli and further molecular characterization
More information-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2002, p. 3156 3163 Vol. 46, No. 10 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.10.3156 3163.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationMICROBIOLOGY LETTERS. Introduction RESEARCH LETTER
RESEARCH LETTER Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China Shuchang An 1, Jichao
More informationPlasmids-Mediated Antibiotic Resistance in E. coli
Plasmids-Mediated Antibiotic Resistance in E. coli (Received: 08.12.1998) Nariman A. H. Aly*; Amany Tharwat** and Wesam F. El-Baz** *Microbial Genetics Dept., Genetic Engineering and Biotechnology Div.,
More informationTitle: Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR
JCM Accepts, published online ahead of print on 11 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.00991-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11
More informationGenetic and Biochemical Characterization of the First Extended-Spectrum CARB-Type ß-Lactamase, RTG-4, from Acinetobacter baumannii
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2009, p. 3010 3016 Vol. 53, No. 7 0066-4804/09/$08.00 0 doi:10.1128/aac.01164-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Genetic
More informationDetection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel
Journal of Antimicrobial Chemotherapy (2009) 64, 718 722 doi:10.1093/jac/dkp272 Advance Access publication 4 August 2009 Detection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from
More informationMultidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015?
Analysis. Answers. Action. www.aphl.org Multidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015? Audrey N. Schuetz, MD, MPH 1 Faculty Disclosure The Association of Public Health
More informationAddress: Department of Microbiology, Pasteur Institute of Iran to 2006, MSc in Microbiology, Al-Zahra University, Tehran, Iran.
Personal Information First name: Vajihe Sadat Family name: Nikbin Nationality: Iranian Marital Status: Single Date and Place of Birth: 1979.3.5, Tehran Address: Department of Microbiology, Pasteur Institute
More informationSupplement 1: Sequences of Capture Probes. Capture probes were /5AmMC6/CTG TAG GTG CGG GTG GAC GTA GTC
Supplementary Appendixes Supplement 1: Sequences of Capture Probes. Capture probes were /5AmMC6/CTG TAG GTG CGG GTG GAC GTA GTC ACG TAG CTC CGG CTG GA-3 for vimentin, /5AmMC6/TCC CTC GCG CGT GGC TTC CGC
More informationSupplemental Data Supplemental Figure 1.
Supplemental Data Supplemental Figure 1. Silique arrangement in the wild-type, jhs, and complemented lines. Wild-type (WT) (A), the jhs1 mutant (B,C), and the jhs1 mutant complemented with JHS1 (Com) (D)
More informationRelationship between Adhesion to Intestinal Caco-2 Cells and Multidrug Resistance in Klebsiella pneumoniae Clinical Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, June 1997, p. 1499 1503 Vol. 35, No. 6 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Relationship between Adhesion to Intestinal Caco-2 Cells
More informationGenetic support of Extended- Spectrum ß-Lactamases
Genetic support of Extended- Spectrum ß-Lactamases Laurent Poirel Dept of Microbiology (Pr Nordmann) Bicêtre Hospital. South-Paris Medical School. France ESCMID Conference on ESBL 29-31 May 2006 TEM-like
More informationVerification of Disk Diffusion Tests
Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of
More informationEPIDEMIOLOGY OF ACINETOBACTER BAUMANNII INFECTIONS IN MULTIPROFILE HOSPITAL
TRAKIA JOURNAL OF SCIENCES Trakia Journal of Sciences, Vol. 10, No 2, pp 59-64, 2012 Copyright 2012 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7050 (print) ISSN 1313-3551 (online)
More informationOXA-198, an Acquired Carbapenem-Hydrolyzing Class D -Lactamase from Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2011, p. 4828 4833 Vol. 55, No. 10 0066-4804/11/$12.00 doi:10.1128/aac.00522-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. OXA-198,
More informationREVIEW. The spread of CTX-M-type extended-spectrum b-lactamases G. M. Rossolini, M. M. D Andrea and C. Mugnaioli
REVIEW The spread of CTX-M-type extended-spectrum b-lactamases G. M. Rossolini, M. M. D Andrea and C. Mugnaioli Dipartimento di Biologia Molecolare, Sezione di Microbiologia, Università di Siena, Siena,
More informationPrevalence of -Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2000, p. 1930 1935 Vol. 44, No. 7 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Prevalence of -Lactamases among
More informationFigure S1. Characterization of the irx9l-1 mutant. (A) Diagram of the Arabidopsis IRX9L gene drawn based on information from TAIR (the Arabidopsis
1 2 3 4 5 6 7 8 9 10 11 12 Figure S1. Characterization of the irx9l-1 mutant. (A) Diagram of the Arabidopsis IRX9L gene drawn based on information from TAIR (the Arabidopsis Information Research). Exons
More informationComparative Characterization of the Cephamycinase bla CMY-1 Gene and Its Relationship with Other -Lactamase Genes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1996, p. 1926 1930 Vol. 40, No. 8 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Comparative Characterization of the Cephamycinase bla
More informationOxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2001, p. 1615 1620 Vol. 45, No. 6 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.6.1615 1620.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationCTX-M-27. Escherichia coli 312 Clinical and Laboratory Standards Institute double-disk synergy test 15 (4.8 ) extendedspectrum
2011 25 b- CTX-M-27 1) 1, 2) 1, 3) 1) 2) 3) 22 7 30 23 1 14 2007 12 2008 2 7 Escherichia coli 312 Clinical and Laboratory Standards Institute double-disk synergy test 15 (4.8 ) extendedspectrum b-lactamase
More information6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics
Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical
More informationβ-lactamase-mediated RESISTANCE TO ANTIMICROBIALS: THE RELATIONSHIP BETWEEN GENOTYPE AND PHENOTYPE
β-lactamase-mediated RESISTANCE TO ANTIMICROBIALS: THE RELATIONSHIP BETWEEN GENOTYPE AND PHENOTYPE Tegan Maree Harris Bachelor of Applied Science (Honours IIa), QUT 2006 School of Biomedical Sciences,
More information1. Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Detection of Pseudomonas aeruginosa Producing Metallo β Lactamases (VIM, SME, AIM) in The Clinical Isolates of Intensive Care Units of Al-Zahra Hospital in Esfahan, Iran Farzin Khorvash 1, Mohammad Reza
More informationANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED
ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED Romney Humphries, Ph.D., DABMM Section Chief, Clinical Microbiology University of California Los Angeles Lost Angeles, CA Susan E. Sharp, Ph.D., DABMM, FAAM
More informationUser manual. Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae
User manual Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae Version 1.3 Date of issue: 24.01.2014 18-0081 48 081-04 INTENDED USE...2 INTRODUCTION
More informationEvaluation of a Double Synergy Differential Test (DSDT) for differential detection of ESBL and AmpC-type
NEW MICROBIOLOGICA, 35, 221-225, 2012 Evaluation of a Double Synergy Differential Test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and
More informationAntibiotic resistance OXA -48 Carbapenem-hydrolyzing β- lactamase (blaoxa-48) gene. genesig Advanced Kit. 150 tests.
TM Primerdesign Ltd Antibiotic resistance OXA -48 Carbapenem-hydrolyzing β- lactamase (blaoxa-48) gene genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Antibiotic
More informationInternational Journal of Current Research in Medical Sciences
Int. J. Curr. Res. Med. Sci. (2016). 2(1): 1 10 International Journal of Current Research in Medical Sciences ISSN: 2454-5716 www.ijcrims.com Coden: IJCRPP(USA) Research Article http://s-o-i.org/1.15/ijcrms-2016-2-1-1
More informationA method for surveillance of antibiotic resistance plasmids
A method for surveillance of antibiotic resistance plasmids Set up of a method for characterization of plasmids carrying extended spectrum beta-lactamase genes Elisabeth Öberg Degree project in biology,
More informationCarbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing Fred C. Tenover,* Rajinder K. Kalsi, Portia P. Williams, Roberta B. Carey,* Sheila Stocker,* David Lonsway,*
More informationAntimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS Broth Microdilution and Disk Diffusion Methods
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2004, p. 5102 5108 Vol. 42, No. 11 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.11.5102 5108.2004 Antimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS
More informationThree Decades of -Lactamase Inhibitors
CLINICAL MICROBIOLOGY REVIEWS, Jan. 2010, p. 160 201 Vol. 23, No. 1 0893-8512/10/$12.00 doi:10.1128/cmr.00037-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Three Decades of
More informationTable S1. Bacterial strains (Related to Results and Experimental Procedures)
Table S1. Bacterial strains (Related to Results and Experimental Procedures) Strain number Relevant genotype Source or reference 1045 AB1157 Graham Walker (Donnelly and Walker, 1989) 2458 3084 (MG1655)
More informationDetection and characterization of extended-spectrum b-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong,
Journal of Antimicrobial Chemotherapy (2005) 55, 326 332 doi:10.1093/jac/dki010 Advance Access publication 28 January 2005 Detection and characterization of extended-spectrum b-lactamases among bloodstream
More informationMolecular methods in medical microbiology: Current and future trends
Bangladesh Journal of Medical Science Vol.10 No.3 Jul 11 Editorial Introduction Molecular methods in medical microbiology: Current and future trends Microbial diseases are the principal causes of morbidity
More informationVerification of Gradient Diffusion Strips
Verification of Gradient Diffusion Strips Objectives 1. Describe gradient diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification
More informationCHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved.
CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? 35 INTRODUCTION In the Program Introduction, you learned that the increase in diabetes in the United States has resulted in a great demand for its treatment,
More informationCarbavance. TANGO-1 phase III trial results. (meropenem-vaborbactam) Conference call 27 th June 2016
Carbavance (meropenem-vaborbactam) TANGO-1 phase III trial results Conference call 27 th June 2016 Legal notices Forward looking statements Statements contained in this presentation about The Medicines
More informationA Novel Class C -Lactamase (FOX-2) in Escherichia coli Conferring Resistance to Cephamycins
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1997, p. 2041 2046 Vol. 41, No. 9 0066-4804/97/$04.00 0 Copyright 1997, American Society for Microbiology A Novel Class C -Lactamase (FOX-2) in Escherichia
More informationReceived 22 August 2006/Returned for modification 26 October 2006/Accepted 2 January 2007
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2007, p. 1304 1309 Vol. 51, No. 4 0066-4804/07/$08.00 0 doi:10.1128/aac.01058-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Evolution
More informationRuning title: identification of a new carbapenem-hydrolyzing class D β-lactamase
AAC Accepts, published online ahead of print on 25 July 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.00522-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationReceived 23 December 2010/Returned for modification 11 January 2011/Accepted 7 February 2011
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1608 1613 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.02607-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Evaluation
More informationPrevalence of bla TEM, bla SHV and bla CTX-M among β-lactamase producing Escherichia coli isolated from tertiary care hospitals in Taif, Saudi Arabia
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 1 Ver. III (Jan. - Feb.2017), PP 11-16 www.iosrjournals.org Prevalence of bla TEM, bla
More informationSupporting Information. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2006
Supporting Information Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2006 Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2006 Supporting Information for Expanding the Genetic
More informationEmergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of Qazvin and Tehran, Iran
Volume 8 Number 3 (June 2016) 168-174 ORIGINAL ARTICLE Emergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of and, Iran Amir Peymani, Taghi Naserpour-Farivar
More informationBRITISH BIOMEDICAL BULLETIN
Journal Home Page www.bbbulletin.org BRITISH BIOMEDICAL BULLETIN Original Genotypic Detection of Cefepime Resistance in Iraqi Clinical Isolates of Pseudomonas aeruginosa Sawsan Sajid AL-Jubori, Israa Mohamed
More information